pI: 8.9996 |
Length (AA): 428 |
MW (Da): 46099 |
Paralog Number:
0
Signal peptide: N | GPI Anchor: N | Predicted trans-membrane segments: 0
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 7 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
118 | 295 | 4uos (A) | 11 | 185 | 13.00 | 0 | 0.04 | 0.662288 | -1.65 |
125 | 315 | 5cwq (A) | 4 | 221 | 29.00 | 0.0041 | 0.71 | 0.735462 | -0.86 |
168 | 260 | 1oqy (A) | 77 | 160 | 32.00 | 0.43 | 0 | 0.33749 | 0.92 |
304 | 427 | 2y78 (A) | 0 | 113 | 44.00 | 0 | 1 | 0.69112 | -0.27 |
336 | 427 | 2pbc (A) | 41 | 136 | 46.00 | 0 | 1 | 0.741353 | -0.68 |
339 | 426 | 3jym (A) | 288 | 382 | 30.00 | 0 | 0.99 | 0.561007 | -0.72 |
367 | 425 | 2f4e (A) | 95 | 156 | 34.00 | 0.024 | 0.3 | 0.41805 | 0.32 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Upper 60-80% percentile | ME49 merozoite. | Hehl AB |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | VEG Tachyzoite, ME49 Tachyzoite. | Gregory |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 20-40% percentile | ME49 Bradyzoite. | Sibley/Greg |
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 0-20% percentile | ME49 Oocyst. | Fritz HM |
Fritz HM | Transcriptomic analysis of toxoplasma development reveals many novel functions and structures specific to sporozoites and oocysts. |
Hehl AB | Asexual expansion of Toxoplasma gondii merozoites is distinct from tachyzoites and entails expression of non-overlapping gene families to attach, invade, and replicate within feline enterocytes. |
Gregory | ToxoDB |
Sibley/Greg | ToxoDB |
Ortholog group members (OG5_129720)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT4G25340 | peptidyl-prolyl cis-trans isomerase FKBP53 |
Arabidopsis thaliana | AT3G12340 | FKBP-like peptidyl-prolyl cis-trans isomerase family protein |
Candida albicans | CaO19.1030 | FKBP-type peptidylprolyl cis/trans isomerase similar to S. cerevisiae FPR3 (YML074C) nucleolar proline rotamase |
Candida albicans | CaO19.8632 | FKBP-type peptidylprolyl cis/trans isomerase similar to S. cerevisiae FPR3 (YML074C) nucleolar proline rotamase |
Cryptosporidium hominis | Chro.70034 | immunophilin/FKBP-type peptidyl-prolyl cis-trans isomerase |
Cryptosporidium parvum | cgd7_210 | fkbp |
Dictyostelium discoideum | DDB_G0285357 | FKBP-type peptidylprolyl cis-trans isomerase |
Drosophila melanogaster | Dmel_CG6226 | FK506-binding protein 1 |
Escherichia coli | b3347 | FKBP-type peptidyl-prolyl cis-trans isomerase (rotamase) |
Giardia lamblia | GL50803_10570 | FKBP-type peptidyl-prolyl cis-trans isomerase |
Neospora caninum | NCLIV_014540 | hypothetical protein |
Oryza sativa | 4335968 | Os04g0446500 |
Saccharomyces cerevisiae | YLR449W | peptidylprolyl isomerase FPR4 |
Saccharomyces cerevisiae | YML074C | peptidylprolyl isomerase FPR3 |
Toxoplasma gondii | TGME49_285850 | peptidyl-prolyl cis-trans isomerase, FKBP-type domain-containing protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
b3347 | Escherichia coli | non-essential | goodall |
TGME49_285850 this record | Toxoplasma gondii | Essentiality uncertain | sidik |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Target | Length | Identity | Alignment span | Linked Drugs | Reference |
---|---|---|---|---|---|---|
Rattus norvegicus | FK506-binding protein 1A | 108 aa | 38.2% | 89 aa | Compounds | References |
Gallus gallus | FK506 binding protein 12 | 108 aa | 39.8% | 103 aa | Compounds | References |
Legionella pneumophila | Outer membrane protein MIP | 233 aa | 28.3% | 187 aa | Compounds | References |
6 literature references were collected for this gene.